The Catalyst Programme encompasses a number of research projects, all aiming to find preventions, treatments and cures for breast cancer. In this episode, we take a closer look into four of them.
New research has revealed that a one year course of a drug called a PARP inhibitor can help to reduce the risk of breast cancer recurrence, and progression to secondary breast cancer, in people with early breast cancer with a change in the BRCA gene.
His Royal Highness met with researchers, donors and supporters to hear about our achievements and how the COVID-19 pandemic has impacted our funded research.
In collaboration with others, Breast Cancer Now has supported research into helping women make sustainable lifestyle changes in order to reduce breast cancer risk.